Apellis Pharmaceuticals, Inc. (APLS)
19.94
-0.59
(-2.87%)
USD |
NASDAQ |
Jan 16, 16:00
20.05
+0.11
(+0.55%)
After-Hours: 20:00
Apellis Pharmaceuticals Shareholders Equity (Annual): 228.54M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Amicus Therapeutics, Inc. | 194.04M |
| Alnylam Pharmaceuticals, Inc. | 67.09M |
| Ionis Pharmaceuticals, Inc. | 588.35M |
| Fortress Biotech, Inc. | 22.74M |
| Sarepta Therapeutics, Inc. | 1.528B |